Tuberculosis News and Research

Latest Tuberculosis News and Research

Novel testing method could simplify widespread tuberculosis screening

Tuberculosis can be tough to detect. Diagnosis usually requires coughing up a sputum sample from the lungs, which can be unpleasant, impractical, and even hazardous.

13 Oct 2022

The potential influence of pre-existing parasitic infections on COVID-19 morbidity

The study reveals that countries with a high malaria prevalence have a lower incidence of COVID-19.

13 Oct 2022

The efficacy of UR GUV devices against aerosolized SARS-CoV-2

Researchers assessed the real-time inactivation of SARS-CoV-2 using ultraviolet-C.

12 Oct 2022

PerkinElmer’s Oxford Immunotec receives U.S. FDA approval for T-cell select to automate clinically superior tuberculosis detection

PerkinElmer’s (NYSE: PKI) Oxford Immunotec today announced the U.S. Food and Drug Administration (FDA) has approved the use of the T-Cell Select™ reagent kit for the automation of its T-SPOT®.TB test workflow for in vitro diagnostic (IVD) use by certified laboratories.

From Oxford Immunotec 6 Oct 2022

Immune cell defect tied to the risk of developing rare bacterial infection

Everyone breathes in Mycobacterium avium complex (MAC) bacteria from time to time, but most people don't get sick.

3 Oct 2022

Researchers devise rules for a faster, more effective way to identify tuberculosis treatments

Imagine you have 20 new compounds that have shown some effectiveness in treating a disease like tuberculosis (TB), which affects 10 million people worldwide and kills 1.5 million each year.

21 Sep 2022

Viable monkeypox virus found in nearly all environmental samples from patient's room in first week of infection

In a new study, researchers investigated the presence of viable monkeypox virus (MPXV) in a room occupied by an infected male patient admitted to the National Centre for Infectious Diseases (NCID), Singapore.

20 Sep 2022

Tufts researchers use machine learning to identify new drug cocktails against tuberculosis

Imagine you have 20 new compounds that have shown some effectiveness in treating a disease like tuberculosis (TB), which affects 10 million people worldwide and kills 1.5 million each year.

14 Sep 2022

Neisseria species are linked to worsening bronchiectasis in patients, study shows

A team of international scientists led by the Nanyang Technological University, Singapore (NTU Singapore) has discovered that Neisseria - a genus of bacteria that lives in the human body - is not as harmless as previously thought, and can cause infections in patients with bronchiectasis, asthma, and chronic obstructive pulmonary disease (COPD).

14 Sep 2022

AI system can quickly and automatically evaluate chest X-rays for TB

An artificial intelligence system detects tuberculosis (TB) in chest X-rays at a level comparable to radiologists, according to a study published in Radiology, a journal of the Radiological Society of North America.

13 Sep 2022

Study shows vaccine-derived poliovirus in infant with severe immunodeficiency

Researchers identified type 3 vaccine-derived poliovirus (VDPV) in an infant.

13 Sep 2022

The impact of the infant gut microbiome on vaccine efficacy

A new study reports the effect of the infant gut microbiome on vaccine efficacy.

13 Sep 2022

Update on SARS-CoV-2 variants detected in animals by USDA

The USDA APHIS has recently updated its web-based dashboard to provide information on all SARS-CoV-2 variants detected in animals

12 Sep 2022

ACTG announces the initiation of trial evaluating the safety and efficacy of monkeypox treatment

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which expanded its focus to conduct research into COVID-19, today announced the initiation of STOMP (Study of Tecovirimat for Human Monkeypox Virus), or A5418, a phase 3, randomized, placebo-controlled, double-blind trial evaluating the safety and efficacy of tecovirimat for the treatment of human monkeypox.

9 Sep 2022

Novel antifungal medications urgently needed to control COVID-19-associated fungal infections

Every day we inhale thousands of potentially pathogenic fungal spores, but our immune system simply eliminates them.

9 Sep 2022

Weill Cornell Medicine receives $5 million NIH grant for next generation TB research

Weill Cornell Medicine has been awarded a five-year, $5 million grant from the National Institutes of Allergy and Infectious Diseases of the National Institutes of Health to establish a new multi-institutional center for tuberculosis (TB) research and training the next generation of TB investigators.

9 Sep 2022

Booster vaccination maintains high efficacy against malaria in African children

Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of the candidate malaria vaccine, R21/Matrix-M™ - which previously demonstrated high-level efficacy of 77% over the following 12 months in young west African children in 2021.

9 Sep 2022

Leopoldina Annual Assembly focuses on broad spectrum of global health issues

The aim of global health is to improve the situation of and equity for the entire global population with respect to health.

6 Sep 2022

Tattoos can induce bloodstream infections

A recent review describes the characteristics of systemic bacterial infections associated with tattoos.

28 Aug 2022

Resistance to recognizing airborne transmission of SARS-CoV-2 may be rooted in historical error

In new research, researchers extensively searched for the origins of the resistance to recognizing airborne transmission during the coronavirus disease 2019 (COVID-19) pandemic by major public health organizations, including the World Health Organization (WHO) and the United States Centers of Disease Control and Prevention (US-CDC).

25 Aug 2022

Tuberculosis News and Research

Latest Tuberculosis News and Research

Novel testing method could simplify widespread tuberculosis screening

The potential influence of pre-existing parasitic infections on COVID-19 morbidity

The efficacy of UR GUV devices against aerosolized SARS-CoV-2

PerkinElmer’s Oxford Immunotec receives U.S. FDA approval for T-cell select to automate clinically superior tuberculosis detection

Immune cell defect tied to the risk of developing rare bacterial infection

Researchers devise rules for a faster, more effective way to identify tuberculosis treatments

Viable monkeypox virus found in nearly all environmental samples from patient's room in first week of infection

Tufts researchers use machine learning to identify new drug cocktails against tuberculosis

Neisseria species are linked to worsening bronchiectasis in patients, study shows

AI system can quickly and automatically evaluate chest X-rays for TB

Study shows vaccine-derived poliovirus in infant with severe immunodeficiency

The impact of the infant gut microbiome on vaccine efficacy

Update on SARS-CoV-2 variants detected in animals by USDA

ACTG announces the initiation of trial evaluating the safety and efficacy of monkeypox treatment

Novel antifungal medications urgently needed to control COVID-19-associated fungal infections

Weill Cornell Medicine receives $5 million NIH grant for next generation TB research

Booster vaccination maintains high efficacy against malaria in African children

Leopoldina Annual Assembly focuses on broad spectrum of global health issues

Tattoos can induce bloodstream infections

Resistance to recognizing airborne transmission of SARS-CoV-2 may be rooted in historical error

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Tuberculosis News and Research

Latest Tuberculosis News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in